Lexeo Therapeutics’ Post

Grig mentions a key automation that solved an important bottleneck: > "For example, when you work with any vendor for a pharmaceutical company, almost everybody requires an NDA to be signed. This by itself can eat up to two weeks of time on both ends of this transaction. We had automated this NDA signing process so that it would usually happen in hours. Many of our vendors would follow up and tell us how insanely fast this was and how it was the smoothest and fastest contracting experience that they had ever had." Some behind the scenes info on this: I built it by wiring up a form builder, make.com and DocuSign. For additional features I synced the current state of each signature request to a Notion Database. Don't forget to build automated tests for core business logic like this, I used cypress to do that. All in all the implementation is the easy part with things like this, the hard part is figuring out which processes to automate to actually generate the most value without doing premature optimization and building unnecessary features. If you want to build something like this without passing the data to third parties, the same thing can be done using self-hosted tools like wpforms, n8n and Nextcloud.

ZONTAL offers a comprehensive FAIR data management platform that streamlines processes, enhances data integrity, and ensures regulatory compliance. In today’s rapidly evolving scientific landscape, efficient data management is critical. Our latest white paper explores the innovative solutions and technologies ZONTAL has developed to tackle these challenges. Download our white paper now to learn more: https://lnkd.in/dcmUHyvD #LifeSciences #DataManagement #FAIR #Innovation #Biotech #Pharma #ScientificResearch #DigitalTransformation #SciY

Are you attending this year's #BayOConnect event? Don't miss the chance to meet our experts Wafa and Angela, and discuss how we can support you in overcoming regulatory challenges and achieving your goals. #BayOConnect #biotech #regulatoryaffairs #pharmaregulatory #healthcare #medicine

This is evidence of how proper planning of #clinicaltrials can have a real impact on their speed and budget. Indegene achieved these incredible results for their client being backed by TrialHub's real-time insights on trials, sites, and patients. Very proud of this project 😊 You can read the full story on our blog (link in the comments) #patientrecruitment #dataanalytics #clinicaloperations #clinicalresearch #biotech #siteselection #patientfeasibility

Thoughts on this? >> Vilya raises $21M in Series A extension; Shionogi to build research center in San Diego >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #productmarketing #pharmaceutical #healthcare #biotech

Thoughts on this? >> Vilya raises $21M in Series A extension; Shionogi to build research center in San Diego >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharmaceutical #biotech #healthcare #pharma

In a recent discussion with Jules ADAM from Labiotech.eu, Manni Kantipudi shared his perspective on the evolving trends in the CDMO industry and the consequences of the BIOSECURE Act on the global biotech landscape. Manni highlighted that the current shift in outsourcing strategies is more durable than the temporary changes seen during the COVID-19 pandemic. “The pandemic underscored that outsourcing is not just a ‘good-to-have’ but a ‘must-have’ for the global life sciences sector. The recent Act and associated controversies are prompting Western pharma and biotech companies to reassess their strategies, marking a significant, long-term shift in approach,” Manni noted. As the industry adapts, Aragen remains at the forefront of providing strategic outsourcing solutions that meet the evolving needs of our clients. Click on the link https://lnkd.in/gahtTa7z to read the full article #biosecureact #cdmotrends #croindustry #lifesciences #postcovid19 #pharmaindustry #biotech #media #industrystory

💡 iBio General Counsel to Participate in Life Sciences Forum 💡 Marc Banjak, iBio, Inc.'s General Counsel, will attend the Life Sciences General Counsel Forum by Consero. This forum is scheduled for January 22–24, 2024, at the Four Seasons Hotels and Resorts in Westlake Village, CA. Marc will participate on a panel for the featured discussion "Balancing Roles: The GC as Corporate Advocate and Business Advisor" on Tuesday, Jan 23rd, at 1:30-2:00 E.T. The forum is renowned for its high-caliber discussions and networking opportunities, providing a platform for industry leaders to share insights & strategies, and thought-provoking dialogues with influential voices in the field. Marc's participation in this forum aligns perfectly with iBio's commitment to staying at the forefront of legal and regulatory advancements in the #biotech industry. We are excited about the insights and connections Marc will bring back from this forum, which will undoubtedly contribute to our ongoing efforts in revolutionizing drug development. #iBioInc #GeneralCounsel #ConseroForum #Biotechnology #LegalExcellence #Innovation #DrugDevelopment

Exciting developments in drug discovery! The recent update to AlphaFold, now AlphaFold3, represents a significant leap forward in protein structure prediction. This breakthrough, highlighted in a May 8, 2024, Nature publication, brings new capabilities for modeling interactions between proteins and various molecules—a major win for drug discovery. However, DeepMind's restriction of AlphaFold3 to non-commercial use limits its potential impact. Read the blog to see where xBxBio steps in. 🔗 Read the blog post here #DrugDiscovery #Biotech #Innovation #Healthcare #Pharmaceuticals #xBxBio https://wix.to/DRDDv4p

High attendance at our panel discussion with representatives of the investor, industry and payer communities highlighting the importance of considering payers‘ perspectives as early as at preclinical stage #marketaccess #payers #biotech #syneoshealth #innovation #swissbiotechday